AFP and hepatocellular carcinoma: Wang et al. found that the combination of serum EV miR-122, EV miR-148a, and AFP could distinguish early-stage HCC from cirrhosis with high accuracy, increasing the AUC to 0.931 (95% CI: 0.857–0.973) [30].